Arndt Vogel, Head of the Center for Personalized Medicine, MHH at Medical University of Hanover, shared a post on X about a recent article by Izuma Nakayama, et al. published in JCO Oncology Practise:
“Durable Complete Response and Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer.
- 51 patients
- 23.5% HER2, 23.3% dMMR, 16.0% CLDN18.2, 30.0% CPS >10
Exciting times with molecular and immunotherapies…”
Title: Durable Complete Response and Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer – A Case Series of Patients
Authors: Shinpei Ushiyama, Takumi Habu, Izuma Nakayama, Mitsumasa Yoshida, Naoya Sakamoto, Akihito Kawazoe, Kazumasa Yamamoto, Dai Okemoto, Yuki Matsubara, Kyosuke Seguchi, Takuya Ogura, Ukyo Okazaki, Yu Miyashita, Akinori Kobayashi, Tadayoshi Hashimoto, Saori Mishima, Daisuke Kotani, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Kazuma Sato, Takeo Fujita, Yoshimasa Shimizu, Masahiro Yura, Takahiro Kinoshita, Kohei Shitara
You can read the full article in JCO Oncology Practise.
More posts about Gastric Cancer.